Owens, Gary M.Journal of Managed Care Medicine
Tailored ways to manage multiple sclerosis and its symptoms While there’s no cure for MS, many treatment options make it possible to manage the symptoms and slow the progression of this condition. MS is different for everyone, so most care plans are highly personalized, often combining elements...
Each stage of multiple sclerosis (MS) or another demyelinating disease brings tons of questions: Is it MS or something else? How do I get a diagnosis? How can I control symptoms? Is there a better treatment for me? We have answers to all these questions and more. Our team offers unmatch...
Mitoxantrone (Novantrone) is achemotherapyagent that has been approved by the FDA to treat multiple sclerosis. Treatment with mitoxantrone requires monitoring of cardiac function, and there is a fixed limit to the dose that can be administered to patients. It also carries the long-term risk ofl...
Featured Centers What Are the Best PsA Treatments for You? Understanding Biologics 10 Things People With Depression Wish You Knew What are the treatments for multiple sclerosis? Many factors go into consideration for the treatment of a patient who has multiple sclerosis. During an acute exacerbati...
Multiple Sclerosis : Multiple Sclerosis Center of Excellence includes the latest research, cases, quizzes, and peer discussion about multiple sclerosis and related comorbidities.
The multiple sclerosis condition center is a resource for clinical news on the diagnosis, treatment, and management of multiple sclerosis. | NeurologyLive.
Multiple sclerosis medications are prescribed to treat multiple sclerosis (MS), an autoimmune disorder that affects the central nervous system (CNS). These medications may prevent or slow down progression of MS and related disabilities, reduce duration a
For instance, dimethyl fumarate is the first FDA-approved Nrf2 activating compound that is currently being used for the treatment of multiple sclerosis [210] and its active metabolite, monomethyl fumarate, has the potential to be conjugated via its readily available carboxylic acid moiety to a ...
W. et al. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49, 351–357 (1997). PubMed Google Scholar Mundt, S. et al. Conventional DCs sample and present ...